http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2710025-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a5c7ef139b183f4fed86986d54656ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb96a0b2da9a06a559f3a26d7c41f5ca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23J1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
| filingDate | 2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794d5971fad32314cc9f8a1a7246646c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7781ebe70c8051e13d679e4c1bb98a78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51053bfd0a1a4c8fd8f05ec41b1ebc39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4d53fb0db949c9423e072065c2521e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1b39f8b290dd9d1dcc2a539abaefc70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c30ccc26eafaa80c5d07e1b573a7afb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e089f167f1861d66a8493d144c7df66 |
| publicationDate | 2019-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2710025-T3 |
| titleOfInvention | Schemes of isolation and sequential protein purification by affinity chromatography |
| abstract | A method of sequential isolation and purification of proteins comprising (i) providing a plasma sample, (ii) providing ligands that bind, each of them, specifically to a target protein of the biological sample, where each of the ligands is optionally attached to a support to form ligand-support complexes, (iii) contacting ligands or ligand-support complexes, sequentially and in a predetermined order, with the plasma sample to allow each ligand or ligand-support complex to selectively the target protein of the plasma sample, where the predetermined order of contacting ligands or ligand-support complexes with the plasma sample results in plasminogen binding before IgG and IgG before albumin, and where, before of said contacting, the biological sample is not processed by a preconditioning stage selected from the group consisting of precipitation with alc ohol, cryoprecipitation, elimination of lipids and / or lipid proteins, precipitation of euglobulin, or a combination thereof, (iv) elute the bound protein bound to each of the ligands or ligand-support complexes, and (v) isolate the target protein sequentially from the biological sample. |
| priorityDate | 2004-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 317.